The Impact of LSD on Brain Function and Neurochemistry

Dr. Sheridan Walter
Dr. Jennie Stanford
Written by Dr. Sheridan Walter on 26 February 2025
Medically reviewed by Dr. Jennie Stanford on 06 March 2025

Since its discovery in 1938 by Swiss chemist Albert Hofmann, lysergic acid diethylamide (LSD) has maintained an unstable relationship with psychiatry, brain function, and neurochemistry. Hofmann synthesized LSD to develop ergot derivatives to reduce postpartum hemorrhage. Some years later, he was the first subject in history to experience its effects on the brain after accidentally coming into contact with a small dose. 

LSD impacts brain function by interrupting and modulating serotonin pathways, a key process in producing its hallucinogenic effects, cognitive shifts, and altered mood.

We will take a brief look at LSD's effects on specific regions in the brain and neurotransmitter pathways and also examine its short- and long-term effects and possible therapeutic benefits.

Key takeaways:
  • LSD disrupts serotonin pathways, causing vivid hallucinations, sensory blending, and cognitive distortions.
  • Its short-term effects range from euphoria to paranoia.
  • Long-term use poses risks, including flashbacks, hallucinogen persisting perception disorder (HPPD), and potential mental health conditions.
a close up photo of an open mouth with a heart shaped LSD pill on the person's tongue, the photo has a blurry quality with vibrant colors

How LSD works in the brain

LSD binds to specific serotonin receptors in the brain, most notably the 5-HT2A receptor, which helps manage mood, perceptions, and thinking. When LSD binds to this receptor, it disrupts normal serotonin signaling and causes different parts of the brain to “talk” to each other in unusual ways. For example, regions that handle sensory experiences (like sight and sound) begin to interact more intensely, which can lead to vivid, emotional, and often unpredictable experiences commonly known as a “trip.”

At the same time, the areas of the brain responsible for clear, logical thinking and self-awareness become less active. This change can result in altered perceptions of time and even a temporary feeling of losing one’s sense of self—a phenomenon often described as “ego dissolution” or “ego death.”

Additionally, LSD lowers the activity of the default mode network (DMN), a network of brain regions that normally support self-reflection and our personal identity. Together, these effects help explain why LSD can dramatically shift how we experience ourselves and the world.

The key areas in the brain affected during this process are:

  • Visual cortex: It becomes hyperactive, which explains the vivid hallucinations and heightened visual perception of colors, patterns, and light.
  • Thalamus: This area is a central hub for sensory information that misinterprets incoming signals, leading to sensory blending or synesthesia—such as hearing colors or seeing sounds.
  • Prefrontal cortex: This region, responsible for logical thinking and self-awareness, shows reduced activity under LSD, contributing to altered time perception and ego dissolution.

Short-term effects of LSD on the brain

LSD changes neurotransmitter function and connectivity between key regions in the brain, leading to the following psychological and perceptual changes:

  • Altered sensory perception
  • Rapid mood changes  
  • Cognitive distortion

Long-term effects of LSD use

Many people who use LSD experience flashbacks of previous “trips,” which are recurrences of effects associated with the drug occurring many days or months after the last dose of LSD. Flashbacks, also known as hallucinogen persisting perception disorder I (HPPD I), are short-term, reversible, and have a benign course. There have been reports of pleasant feelings accompanying the re-emergence of visual images, and people sometimes refer to this phenomenon as a free trip. However, some people may experience these flashbacks as distressing or intrusive, though they typically do not cause long-term impairment.

HPPD II differs from HPPD I, as it follows a long-term, irreversible, or slowly reversible and pervasive trajectory. The impairment of HPPD II is severe, and the prognosis is worse. Some patients struggle to adapt and cope with these persistent, recurring "trips," and a consistent portion of people require ongoing support and treatment.

Prolonged exposure can also lead to mood disorders, anxiety, and psychosis in vulnerable people due to long-term cognitive changes and potential impacts on neuroplasticity. People with certain genetic predispositions who use LSD are also at risk of developing schizophrenia.

Does LSD damage brain cells?

LSD does not damage or kill brain cells. Its effects on the brain are primarily functional and temporary, meaning it alters neuronal communication by modulating neurotransmission and hyperactivating serotonin 5-HT2A receptors.

LSD's therapeutic potential

LSD may hold clinical promise, particularly in treating:

Final thoughts

LSD’s effects on the brain are salient and complex, disrupting serotonin signaling and altering functional connectivity, which changes perception, cognition, and self-awareness. Potent effects that contribute to LSD's reputation as a powerful psychedelic also come with psychological risks, particularly for individuals predisposed to mental health conditions.

A growing body of clinical research indicates that LSD does have therapeutic value; this, however, requires further studies, particularly for depression, anxiety, and addiction. However, its legal status and issues around long-term safety make advances in these areas challenging.

As scientific understanding of psychedelics advances, the conversation around LSD is evolving as a research tool, a therapeutic aid, and a recreational substance. Its role in neuroscience and mental health remains a fascinating and rapidly developing field that we will continue to follow and report on.

FAQs

Common questions about LSD

What is LSD?

LSD is a hallucinogenic drug derived from ergot fungus with psychedelic and mind-altering effects.

How long do the effects of LSD last, and how long does it stay in the body?

LSD’s effects last 8-12 hours, and its traces may remain in the body for up to 2 days.

What are the potential risks and dangers associated with LSD use?

LSD may cause anxiety, panic attacks, paranoia, psychosis, flashbacks, and potential psychological disorders in people with a predisposition (people who are vulnerable to developing these risks).

In what forms is LSD typically found, and how is it made?

LSD is available in blotter paper, tablets, or liquid form. It is synthesized from the lysergic acid found in ergot fungi.

Does LSD have any current medical applications?

LSD is not approved for mainstream medical use. There are, however, ongoing clinical trials investigating its therapeutic potential in treating existential anxiety in terminally ill patients, addiction, and general anxiety disorder.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Fuentes, J. J., Fonseca, F., Elices, M., Farré, M., & Torrens, M. (2020). Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials. Frontiers in Psychiatry, 10, 943.
  2. Bedford, P., Hauke, D. J., Wang, Z., Roth, V., Holze, F., Ley, L., Vizeli, P., Liechti, M. E., Borgwardt, S., Müller, F., & Diaconescu, A. O. (2023). The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity. Neuropsychopharmacology, 48(8), 1175-1183.
  3. Gattuso, J. J., Perkins, D., Ruffell, S., Lawrence, A. J., Hoyer, D., Jacobson, L. H., Timmermann, C., Castle, D., Rossell, S. L., Downey, L. A., Pagni, B. A., Galvão-Coelho, N. L., Nutt, D., & Sarris, J. (2022). Default Mode Network Modulation by Psychedelics: A Systematic Review. International Journal of Neuropsychopharmacology, 26(3), 155.
  4. López-Giménez, J. F., & González-Maeso, J. (2018). Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways. Current Topics in Behavioral Neurosciences, 36, 45.
  5. Luppi, A. I., Carhart-Harris, R. L., Roseman, L., Pappas, I., Menon, D. K., & Stamatakis, E. A. (2021). LSD alters dynamic integration and segregation in the human brain. Neuroimage, 227, 117653.
  6. G Lerner, A., Rudinski, D., Bor, O., & Goodman, C. (2014). Flashbacks and HPPD: A Clinical-oriented Concise Review. The Israel journal of psychiatry and related sciences, 51(4), 296–301.
  7. Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M. C., Lorusso, M., & Lerner, A. G. (2018). Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sciences, 8(3), 47.
  8. Holze, F., Gasser, P., Müller, F., Dolder, P. C., & Liechti, M. E. (2023). Lysergic Acid Diethylamide-Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II Study. Biological psychiatry, 93(3), 215–223.
  9. Jing, X., Hoeh, N. R., & Menkes, D. B. (2023). Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022. Palliative & supportive care, 21(4), 697–704.
  10. Stringer, H. (2024, June 1). The emergence of psychedelics as medicine.Monitor on Psychology, 55(4), 50.

Activity History - Last updated: 06 March 2025, Published date:


Reviewer

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Jennie Stanford, MD, FAAFP, DipABOM is a dual board-certified physician in both family medicine and obesity medicine. She has a wide range of clinical experiences, ranging from years of traditional clinic practice to hospitalist care to performing peer quality review to ensure optimal patient care.

Activity History - Medically Reviewed on 26 February 2025 and last checked on 06 March 2025

Medically reviewed by
Dr. Jennie Stanford

Dr. Jennie Stanford

MD, FAAFP, DipABOM

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

For any specific questions please email us at info@recovered.org

Related guides